Trial reportObesity surgery2026
Improving the SF-BARI Score with a Structured Postoperative Exercise Program: A Randomized Trial after Metabolic and Bariatric Surgery.
Trial report in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application of the SF-BARI Score for Evaluating long-term Metabolic and Clinical Outcomes after Bariatric Surgery.Obesity surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionObesity is a complex and multifaceted condition that can lead to serious health issues. Bariatric surgery, particularly Roux-en-Y gastric bypass (RYGB), is highly effective treatment for severe obesity but may often leads to significant skeletal muscle loss, compromising long-term metabolic outcomes. Structured exercise may mitigate these effects, yet its impact on comprehensive surgical success remains underexplored. This randomized controlled trial evaluated the synergistic effects of a 16-week combined exercise program on the SF-BARI score, a holistic composite measure of weight loss and comorbidity remission, in post-RYGB patients.
methodsThirty-seven patients (mean age 46.9 ± 11.4 years, BMI 42.9 ± 5.14 kg/m²) underwent RYGB and were randomized to a supervised intervention group (IG, n = 19) or control group (CG, n = 17). The IG completed three 55-minute sessions weekly (aerobic and resistance training) starting one month post-surgery for 16 weeks. Outcomes, including anthropometry, percentage total weight loss (%TWL), SF-BARI score (integrating %TWL and remission of type 2 diabetes mellitus, hypertension, dyslipidemia, and obstructive sleep apnea), and complications, were assessed at one, five, eleven, and seventeen months post-surgery.
resultsBoth groups achieved substantial weight loss (%TWL: IG 37% vs. CG 32.5% at 17 months after surgery and 12 months after exercise program, p = 0.139, d = 0.506), with no between-group differences in BMI or weight. However, the IG showed superior SF-BARI scores at 5 months after surgery and immediately after the exercise program (T0-months: 104 ± 13.8 vs. 92.3 ± 12, p = 0.012, d = 0.883) and 11 months after surgery and 6-months after the exercise program (T6-months: 107 ± 13.2 vs. 96.2 ± 16.8, p = 0.007, d = 0.526), driven by enhanced remission of hypertension (0% vs. 41.2%, p = 0.002) and dyslipidemia (0% vs. 23.5%, p = 0.025) at 17 months. Type 2 diabetes mellitus remission was high in both (> 94%, p = 0.935), and effect sizes indicated large clinical benefits in the short-to-medium term.
conclusionsA 16-week combined exercise program post-RYGB significantly improves comprehensive outcomes via the SF-BARI score, enhancing metabolic comorbidity resolution beyond weight loss alone. These findings support integrating supervised exercise into postoperative care to optimize surgical outcomes. Sustained interventions may be needed for long-term gains.
Indexed as
Identifiers
41348144What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.